NCT04420572View on ClinicalTrials.gov

Comparison of Ozone and Steroid Injection in Patients With Greater Trochanteric Pain Syndrome

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 11, 2021

Primary Completion Date

June 1, 2021

Study Completion Date

August 1, 2021

Conditions
Trochanteric Bursitis
Interventions
DRUG

ozone injection

ozone injection will be applied in three doses (1st, 4th, 7th and 10th days) for a total of 4 doses. In ozone injection applications, 1st dose 25 gamma, 2nd dose 20 gamma, 3rd and 4th dose 15 gamma 10 cc ozone will be injected.

DRUG

betamethasone

1ml betamethasone will be used for steroid injection.

Trial Locations (1)

34000

Sultan 2.Abdülhamid Han Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

OTHER

NCT04420572 - Comparison of Ozone and Steroid Injection in Patients With Greater Trochanteric Pain Syndrome | Biotech Hunter | Biotech Hunter